キャリアスクリーニングの世界市場予測（～2024年）...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.4 Years Covered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders
2 Research Methodology (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 Revenue Mapping-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary (Page No. – 28)
4 Premium Insights (Page No. – 32)
4.1 Market Overview
4.2 Europe: Market Share, By Type and Country (2019)
4.3 Market, By Medical Condition
4.4 Market, By Technology (USD Million) (2019 vs 2024)
4.5 Market, By End User (USD Million) (2019 vs 2024)
5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Emphasis on Early Disease Detection and Prevention
5.2.1.2 High Risk of Chromosomal Abnormalities With Advancing Maternal Age
5.2.1.3 Technological Advancements
5.2.2 Opportunities
5.2.2.1 Increasing Awareness of Carrier Screening
5.2.3 Challenges
5.2.3.1 Lack of Skilled Professionals
5.2.3.2 Lack of Standard Guidelines for Carrier Screening
6 Carrier Screening Market, By Product & Service (Page No. – 40)
6.1 Introduction
6.2 Services
6.2.1 Rising Number of Accredited Laboratories is the Major Indicator of Market Growth
6.3 Products
6.3.1 Expanding Use of Carrier Screening Tests has Driven Growth in the Products Market
7 Carrier Screening Market, By Type (Page No. – 45)
7.1 Introduction
7.2 Expanded Carrier Screening
7.2.1 Predesigned Panel Testing
7.2.1.1 Predesigned Panel Testing Accounts for the Largest Market Share
7.2.2 Customized Panel Testing
7.2.2.1 Customized Panels Allow for Specific Sets of Conditions to Be Screened
7.3 Targeted Disease Carrier Screening
7.3.1 Introduction of Panels Capable of Simultaneously Screening Multiple Conditions has Driven Market Growth
8 Carrier Screening Market, By Medical Condition (Page No. – 52)
8.1 Introduction
8.2 Pulmonary Conditions
8.2.1 Increasing Awareness About Cystic Fibrosis and Customized Services Likely to Boost Market Growth
8.2.2 Carrier Screening Products/Services for Cystic Fibrosis
8.3 Hematological Conditions
8.3.1 Rising Prevalence of Hematological Disorders has Increased the Use of Expanded Carrier Screening Panels
8.4 Neurological Conditions
8.4.1 Growing Number of Awareness Programs for Neurological Screening and Presence of Targeted Screening Panels to Support Market Growth
8.4.2 Global Prevalence of Neurological Conditions
8.4.3 Carrier Screening Products/Services for Neurological Conditions
8.5 Other Medical Conditions
9 Carrier Screening Market, By Technology (Page No. – 61)
9.1 Introduction
9.2 Dna Sequencing
9.2.1 Increasing Need to Detect Multiple Genes Simultaneously is Driving Demand for NGS
9.3 Polymerase Chain Reaction
9.3.1 Rising Number of Carrier Screening Tests for Targeted Chromosomal Conditions has Increased the Use of PCR
9.4 Microarrays
9.4.1 Clinical Validity of Microarray in Carrier Screening has Increased Its Use in Reference Laboratories
9.5 Other Technologies
10 Carrier Screening Market, By End User (Page No. – 70)
10.1 Introduction
10.2 Hospitals
10.2.1 Hospitals Formed the Largest End-User Segment in the Market
10.3 Reference Laboratories
10.3.1 Advantages Offered By Reference Laboratories in Terms of Service Costs and Turnaround Time to Support Market Growth
10.4 Physician Offices and Clinics
10.4.1 Large Number of Physician Offices and Clinics are Outsourcing Carrier Screening Testing Services
10.5 Other End Users
11 Carrier Screening Market, By Region (Page No. – 78)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 US Was the Largest Market for Carrier Screening Products and Services Globally in 2018
11.2.2 Canada
11.2.2.1 Awareness Programs, Campaigns, and Conferences are Promoting Carrier Screening in Canada
11.3 Europe
11.3.1 Germany
11.3.1.1 Rising Prevalence of Genetic Disorders to Support Market Growth in Germany
11.3.2 UK
11.3.2.1 High Incidence of Genetic Abnormalities to Drive the Demand for Preconception Screening in the UK
11.3.3 France
11.3.3.1 Government Initiatives Focused on Genomics Research are Expected to Support the Growth of the Market in France
11.3.4 RoE
11.4 Asia Pacific
11.4.1 Increasing Government Support Will Aid the Growth of This Market
11.5 RoW
11.5.1 The RoW Market is Significantly Smaller Than Other Regional Markets
12 Competitive Landscape (Page No. – 107)
12.1 Introduction
12.2 Market Ranking Analysis
12.3 Competitive Leadership Mapping (2019)
12.3.1 Vendor Inclusion Criteria
12.3.2 Visionary Leaders
12.3.3 Innovators
12.3.4 Dynamic Differentiators
12.3.5 Emerging Companies
12.4 Competitive Scenario
12.4.1 Key Product and Service Launches
12.4.2 Key Acquisitions
12.4.3 Key Partnerships and Collaborations
13 Company Profile (Page No. – 112)
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 Eurofins Scientific
13.2 Invitae Corporation
13.3 Opko Health
13.4 Fulgent Genetics Inc
13.5 Quest Diagnostics Incorporated
13.6 Sema4
13.7 Myriad Genetics
13.8 Illumina Inc
13.9 Thermo Fisher Scientific Inc
13.10 Luminex Corporation
13.11 Natera Inc
13.12 Laboratory Corporation of America Holdings
13.13 BGI
13.14 Gene By Gene
13.15 Progenity
13.16 Otogenetics Corporation
13.17 Centogene
13.18 Pathway Genomics
13.19 Medgenome
13.20 True Health
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
14 Appendix (Page No. – 143)
14.1 Discussion Guide
14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.3 Available Customizations
14.4 Related Reports
14.5 Author Details